R1 RCM (NASDAQ:RCM) Announces Earnings Results

R1 RCM (NASDAQ:RCM) issued its earnings results on Tuesday. The healthcare provider reported ($0.05) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.04), Briefing.com reports. R1 RCM had a negative return on equity of 1.44% and a negative net margin of 1.68%. The firm had revenue of $656.80 million during the quarter, compared to analyst estimates of $640.93 million. The firm’s revenue was up 14.7% on a year-over-year basis.

R1 RCM Stock Performance

Shares of NASDAQ RCM traded up $0.01 during mid-day trading on Thursday, hitting $14.28. The company had a trading volume of 2,613,925 shares, compared to its average volume of 3,478,269. The company has a market capitalization of $6.03 billion, a price-to-earnings ratio of -95.13 and a beta of 0.84. R1 RCM has a 1 year low of $8.87 and a 1 year high of $15.12. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.77. The stock’s 50-day moving average price is $14.18 and its 200-day moving average price is $13.29.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on RCM. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $14.30 target price on shares of R1 RCM in a report on Friday, October 4th. Morgan Stanley cut R1 RCM from an “overweight” rating to an “equal weight” rating in a research note on Thursday, August 8th. Stephens cut R1 RCM from an “overweight” rating to an “equal weight” rating in a research note on Thursday, August 1st. Canaccord Genuity Group reissued a “buy” rating and issued a $15.00 price target on shares of R1 RCM in a research note on Monday, July 22nd. Finally, Leerink Partnrs cut R1 RCM from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Thirteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $15.41.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.